-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Downgrades Amicus Therapeutics to Hold, Lowers Price Target to $14.5

Benzinga·01/22/2026 13:15:34
Listen to the news
Jefferies analyst Dennis Ding downgrades Amicus Therapeutics (NASDAQ:FOLD) from Buy to Hold and lowers the price target from $16 to $14.5.